Does autoimmune disease impair the survival of hepatocellular carcinoma patients undergoing liver resection? A multi-institutional observational study.
Chao-Wei LeeHsing-Yu ChenPing-Han TsaiWei-Chen LeeChih-Chi WangMing-Chin YuChun-Wei ChenPo-Ting LinBo-Huan ChenSheng-Fu WangPei-Mei ChaiHsin-I TsaiPublished in: Journal of cancer research and clinical oncology (2024)
Our study demonstrated that autoimmune disease does not impair the OS and DFS of HCC patients undergoing liver resections. AD itself is not a risk factor for tumor recurrence after surgery. Patients eligible for liver resections, as a result, should be considered for surgery irrespective of the presence of AD. Further studies are mandatory to validate our findings.